Additionally, IL11 and IL11Rα overexpression are associated with tumour progression, growth and differentiation and poor prognosis in colorectal [16], gastric [43], hepatocellular [44] and breast [45] cancers. This evidence concerns the gene IL11RA and neoplasm.